Estimating the mitochondrial mutation rate in plasmatic extracellular vesicles from patients with pancreatic cancer showed an increased number of variants in MT-ND1, MT-CYB, and MT-ND5 genes in comparison with controls [75]. This evidence concerns the gene MCAT and pancreatic neoplasm.